eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Rosemont Pharmaceuticals Limited
Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, Yorkshire, LS11 9XE
Telephone: +44 (0)113 244 1400
Fax: +44 (0)113 246 0738
WWW: http://www.rosemontpharma.com
Customer Care direct line: +44 (0)800 919 312
Out of Hours Telephone: +44 (0)7836 557 879
Out of Hours contact: pharmacovigilance@rosemontpharma.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 06/04/2011
PIL Dexsol 2mg/5ml Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/04/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 27/08/2008 and displayed until 06/04/2011
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 14/04/2008 and displayed until 27/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 26/09/2006 and displayed until 14/04/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to Further Information section
Updated on 21/09/2006 and displayed until 26/09/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to Further Information section
Updated on 31/07/2002 and displayed until 21/09/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 22/11/2001 and displayed until 31/07/2002
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  dexamethasone sodium phosphate